Phase I Safety Study of Anti-HIV Immune Serum Globulin (Human)

A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of a 200-mcg Dose

NCT00001056 ·Status: COMPLETED ·Phase: PHASE1

A Phase I Safety and Immunogenicity Trial of UBI Microparticulate Monovalent HIV-1 MN Peptide Immunogen in HIV-1 Seronegative Human Subjects

NCT00000798 ·Status: COMPLETED ·Phase: PHASE1

Umbrella Study for HIV Infected Adults Enrolled in NIAID-Funded Interleukin-2 Studies

NCT00311688 ·Status: COMPLETED

Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)

NCT00001041 ·Status: COMPLETED ·Phase: PHASE1

A Phase I Study of the Safety and Immunogenicity of rgp120/HIV-1IIIB Vaccine in Healthy Adult Subjects (NOTE: Study Extended ONLY for Subjects Who Have Previously Received rgp120/HIV-1IIIB or rgp120/HIV-1MN on VEU 006 or VEU 006 Rollover Study)

NCT00001020 ·Status: COMPLETED ·Phase: PHASE1

Immune Responses to HIV in Blood Cells in HIV-Infected and HIV-Uninfected Volunteers

NCT00027482 ·Status: COMPLETED

A Phase I/II Study of Hyperimmune IVIG in Slowing Progression of Disease in HIV-Infected Children

NCT00000827 ·Status: COMPLETED ·Phase: PHASE1

N-803 Combined With the Broadly Neutralizing Antibodies Plus or Minus haNK Cells for HIV

NCT04144335 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

Screening HIV-Infected Patients for Vaccine Studies

NCT00051519 ·Status: COMPLETED

A Phase I/II Double-Blind Controlled Trial to Determine the Safety and Immunogenicity of HIV-1 MN rgp160 Immuno AG Vaccine Therapy in HIV-Infected Individuals With Greater Than or Equal to 500/mm3 CD4+ T Cells and 200-400/mm3 CD4+ T Cells

NCT00000822 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Trial To Evaluate the Toxicity and Antiviral Effects of a Range of Doses of Ampligen in p24 Antigen Positive HIV-Infected Patients With AIDS or ARC

NCT00000735 ·Status: COMPLETED ·Phase: PHASE1

Safety and Immune Response Assessment Study of Killed-whole HIV-1 Vaccine (SAV001-H) in Chronic HIV-1 Infected Patients

NCT01546818 ·Status: COMPLETED ·Phase: PHASE1

Evaluating the Safety and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults Who Have Participated in Previous HIV Vaccine Clinical Trials and in Adults Who Have Not Participated in Previous HIV Vaccine Clinical Trials

NCT01376726 ·Status: COMPLETED ·Phase: PHASE1

Selection of a Protective T Cell-based HIV-1/FIV Vaccine

NCT02389595 ·Status: ACTIVE_NOT_RECRUITING

Phase 3 Study of Immune Globulin Intravenous (Human)IVIG-SN™ in Subjects With Primary Immunodeficiency

NCT01406470 ·Status: COMPLETED ·Phase: PHASE3

A Pilot Study of Immunization With HIV-1 Antigen Pulsed Allogenic Dendritic Cells in HIV-Infected Asymptomatic Patients With CD4+ T Cells > 350 Cells/mm3

NCT00001064 ·Status: TERMINATED ·Phase: NA

A Phase I Study of the Safety and Immunogenicity of Rgp 120/HIV-1IIIB Vaccine in HIV-1 Seropositive Adult Volunteers

NCT00001992 ·Status: COMPLETED ·Phase: PHASE1

A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Immuno-AG Recombinant HIV gp160 in Asymptomatic HIV Seropositive Individuals

NCT00000633 ·Status: COMPLETED ·Phase: PHASE1

A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of Accelerated Schedules

NCT00000957 ·Status: COMPLETED ·Phase: PHASE1

A Study of HIV in Newly Infected Individuals

NCT00000930 ·Status: COMPLETED

H1N1 Influenza Vaccine Immunogenicity in HIV-1 Infected Patients

NCT01111162 ·Status: COMPLETED ·Phase: PHASE4

Effectiveness of an HIV Vaccine in HIV-Negative Adults in North America Who Are at Risk of HIV Infection

NCT00002441 ·Status: COMPLETED ·Phase: PHASE3

Proof of Principle Study of Pulse Dosing of IL-15 to Deplete the Reservoir in HIV Infected People

NCT02191098 ·Status: COMPLETED ·Phase: PHASE1

A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived HIV-1 Recombinant Envelope Glycoprotein (gp160)

NCT00000968 ·Status: COMPLETED ·Phase: PHASE1

A Study of 1592U89 in HIV-Infected Adults

NCT00002200 ·Status: COMPLETED ·Phase: NA